| Target Price | $8.67 |
| Price | $3.47 |
| Potential |
149.86%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target Alpha Tau Medical 2026 .
The average Alpha Tau Medical target price is $8.67.
This is
149.86%
register free of charge
$12.60
263.11%
register free of charge
$5.05
45.53%
register free of charge
|
|
| A rating was issued by 10 analysts: 9 Analysts recommend Alpha Tau Medical to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Alpha Tau Medical stock has an average upside potential 2026 of
149.86%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.45 | -0.50 |
| 7.14% | 11.11% | |
| P/E | negative |
6 Analysts have issued a Alpha Tau Medical forecast for earnings per share. The average Alpha Tau Medical EPS is
This results in the following potential growth metrics and future valuations:
Alpha Tau Medical...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Oct 22 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 03 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 29 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 17 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 22 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Oct 22 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 03 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 29 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 17 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 22 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


